Characteristics of neuropilin-1 (NRP1) as a target of antiangiogenic activity of immunomodulatory drugs in multiple myeloma
2014/13/B/NZ6/02141
Keywords
Descriptors
- NZ6_2: Immunologia kliniczna
Panel
NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution
Uniwersytet Medyczny w Lublinie, II Wydział Lekarski z Oddziałem Anglojęzycznym
Voivodeship: lubelskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
OPUS 7 – announced on 2014-03-17
- Amount awarded
- 686 500 PLN
- Project start date
- 2015-01-23
- Project end date
- 2018-01-22
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project settled
Equipment purchased [PL]
- mikroskop. Cost: 30 000 PLN
Information in the final report
Publication in academic press/journals (2)
-
Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group.
- Authors:
- Grzasko N, Hajek R, Hus M, Chocholska S, Morawska M, Giannopoulos K, Czarnocki K, Druzd-Sitek A, Pienkowska-Grela B, Rygier J, Usnarska-Zubkiewicz L, Dytfeld D, Kubicki T, Jurczyszyn A, Korpysz M, Dmoszynska A.
- Academic press:
- Leukemia and Lymphoma (year: 2017, volume: 46038, pages: 46037), Publisher: Taylor & Francis
- Status:
- Published
- DOI:
- 10.1080/10428194.2016.1272684 – link to the publication
-
Expression and Clinical Significance of Neuropilin-1 in Patients With Multiple Myeloma
- Authors:
- Karczmarczyk A, Bilska S, Korpysz M, Purkot J, GrzĄŚko N, Hus M, Giannopoulos K.
- Academic press:
- Anticancer Res. (year: 2020, volume: 40(10), pages: 5437-5443), Publisher: Stanford University HighWire Press
- Status:
- Published
- DOI:
- 10.21873/anticanres.14554 – link to the publication